DaVita Inc. logo

DaVita Inc. 0I7E

Market Closed
6 Sep, 15:30
LSE LSE
$
150. 91
+1.54
+1.03%
$
12.75B Market Cap
- P/E Ratio
0% Div Yield
362 Volume
- Eps
$ 149.37
Previous Close
Day Range
148.33 151.64
Year Range
71.56 156.38

0I7E Chart

DaVita Inc. Profile

Medical Care Facilities Industry
Healthcare Sector
Mr. Javier J. Rodriguez CEO
LSE Exchange
US23918K1088 ISIN
United States Country
70,000 Employees
- Last Dividend
9 Sep 2013 Last Split
- IPO Date
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Contact Information

Address: 2000 16th Street
Phone: 720 631 2100